Paul Johnson on Selling Lemonaid Health for $400 Million The $400M sale of Lemonaid Health to 23andMe wasn't luck. It was the result of a deliberate strategy. Here’s the playbook for building a company that gets acquired and navigating the deal. TL;DR: Paul Johnson's $400M sale of Lemonaid Health to 23andMe offers a blueprint for founders. Building for a strategic exit requires targeting a massive market, preparing for M&A conversations early, and mastering the key terms of a deal, from the LOI to the employee retention pool. This is how you navigate your own strategic acquisition. Key takeawaysIdentify your potential strategic acquirers before they contact you.Prepare a virtual data room long before you get an inbound offer.Master the key terms in a Letter of Intent beyond just the price.Understand the difference between cash and stock consideration.Appoint a deal lead to manage diligence so you can keep running the business.Model your exit waterfall to understand what everyone on the cap table gets. The Anatomy of a $400 Million Strategic Exit When 23andMe bought telehealth startup Lemonaid Health for $400 million, it wasn’t just a big number. It was a masterclass in building for a strategic acquisition. For you, the founder, this deal is a playbook. It reveals how to build a company that a market leader needs to own and how to navigate the high-stakes M&A process when they come knocking. Paul Johnson, Lemonaid's co-founder, and his investors, including Sierra Ventures and Health Velocity Capital, didn’t just build a telehealth feature. They built a full-stack prescription and delivery business in a massive, regulated industry. That strategic depth is what commanded a premium price. Let's break down the mechanics of a deal like this and what you need to do to prepare. Step 1: Build a Company That Is Built to Be Bought Strategic acquirers don't buy you to continue your business as-is. They buy you to fill a major gap in their own strategy. 23andMe had genetic testing data but no way to help customers act on it. Lemonaid provided the missing piece: a platform for virtual care and prescription delivery. This wasn't an accident. It was a textbook strategic fit. You need to know your fit years before an offer arrives. Identify Your Strategic Buyers Who are the 5-10 public companies in your ecosystem for whom you could be a missing piece? Don’t guess. Read their annual 10-K reports and listen to their CEO’s investor day presentations. They will state their strategic priorities explicitly. If a CEO says, "Our future is closing the loop between diagnostics and proactive care," and you run a telehealth company, you are on their M&A target list. Common Founder Mistake: Only thinking about your direct competitors. Your most likely strategic acquirer is often an adjacent player who wants to enter your market and would rather buy than build. Step 2: Master the M&A Conversation The first call won't be from the CEO. It will be from a Director or VP of Corporate Development. Their job is to screen targets. You need to sound like you know the game. The First Call Playbook Your goal is not to sell them. It’s to qualify them. Are they serious? Do they have a clear thesis? Or are they just fishing for information? Your script for the first inbound email: Continue reading the full guide Related guidesThe E Ink Story: Lessons On Fundraising For Hard Tech From An $8B CompanyBarrett Comiskey: Building An $8 Billion Business On Deep TechRalf Wenzel Has Built 3 Unicorns: Here Is His Founder PlaybookRalf Wenzel's Playbook For Building 3 UnicornsHow Facet's Founder Raised 58M by Targeting Market FailureHow A Founder Raised 50M Across Two Companies Read on Startup Fundraising · More articles · Browse the Library More from Startup FundraisingHealthtech — State Of Investing 2026Climate In Seattle Wa — State Of Funding 2026Fintech — Most Backed Startups 2026SolegreenOwlAnish Agarwal TraversalEric SteenCity — Nashville TnBacked By — Ketch VenturesIndustry — Financial ServicesBacked By Investor — Jamie ShortillIndustry — BiotechCity — Bogot ColombiaIndustry — SaasCity — San Francisco CaIndustry — Ai InfrastructureDavid Brookman D635d6Alternatives — Frank J Capella 2d694e Library homeFull library indexArticlesHomeInvestor directoryFounder directoryCompany funding databaseResearch hubPricing Karen FallenKarina OdinaevKarl MehtaKarthik KannanKate FriedmannKatherine RuffnerRyno BlignautJason RischBryce YoungrenRobert ConeybeerRob ChaplinskyJason Green
